Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
HPV-Related Carcinoma: early-phase trial registry
6 of 11 indexed HPV-Related Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,577 of 28,707 conditions by registered trial count.
11 US clinical trials · 6 currently recruiting · #1,577 of 28,707 conditions by registered trial count
HPV-Related Carcinoma: 11 US clinical trials tracked, 6 recruiting.
HPV-Related Carcinoma is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is Christian Hinrichs, running 2 of these trials.
Enrollment posture brief
Registry condition hpv-related-carcinoma
OPEN 6 | RECR 55% | LATE 0 | EARLY 8 | RANK #1577 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Advanced Ovarian Carcinoma (55% recruiting · 11 trials)
HPV-Related Carcinoma lists 6 open slots (55% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for HPV-Related Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
HPV-Related Carcinoma is recruiting above its size-band peers.
6 of 11 indexed trials (54.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates HPV-Related Carcinoma research.
Christian Hinrichs accounts for 2 of 11 trials (18.2%). 9 distinct sponsors appear on at least one study for this condition label.
-
Most HPV-Related Carcinoma trials plan to enrol fewer than 100 people.
Median target enrolment is 20 among the 11 trials that report a genuine target (sentinel values excluded). 8 of those (72.7%) plan for fewer than 100 participants.
-
HPV-Related Carcinoma research is mostly interventional.
8 interventional and 3 observational studies make up this index (72.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
11 total, page 1 of 1
Biomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
H. Lee Moffitt Cancer Center and Research Institute
NCT06305676
PRGN-2009 in Combination With Pembrolizumab Versus Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Precigen
NCT06157151
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
Memorial Sloan Kettering Cancer Center
NCT05307939
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Christian Hinrichs
NCT05686226
Detecting HPV DNA in Anal and Cervical Cancers
University of Chicago
NCT04857528
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
Christian Hinrichs
NCT05639972
A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors
TScan Therapeutics
NCT05973487
Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers
Transgene
NCT03260023
Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer
University of Michigan Rogel Cancer Center
NCT06234748
IBRX-042 In Participants With HPV-Associated Tumors
ImmunityBio
NCT05976828
A Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)
Memorial Sloan Kettering Cancer Center
NCT05814549
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on HPV-Related Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on HPV-Related Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this HPV-Related Carcinoma page
11 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 HPV-Related Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Christian Hinrichs sponsors the most HPV-Related Carcinoma trials on record, review their full trial history before evaluating a specific study. See Christian Hinrichs's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This HPV-Related Carcinoma condition card totals 11 registered trials; most-linked intervention E7 TCR-T cells; top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.